TY - JOUR AU - Alongi, F. AU - Mazzola, R. AU - Fiorentino, A. PY - 2019 DA - 2019// TI - Phase II study of accelerated Linac-based SBRT in five consecutive fractions for localized prostate cancer JO - Strahlenther Onkol VL - 195 UR - https://doi.org/10.1007/s00066-018-1338-7 DO - 10.1007/s00066-018-1338-7 ID - Alongi2019 ER - TY - JOUR AU - Katz, A. PY - 2017 DA - 2017// TI - Stereotactic body radiotherapy for low-risk prostate Cancer: a ten-year analysis JO - Cureus VL - 9 ID - Katz2017 ER - TY - JOUR AU - Bari, B. AU - Arcangeli, S. AU - Ciardo, D. PY - 2016 DA - 2016// TI - Extreme hypofractionation for early prostate cancer: biology meets technology JO - Cancer Treat Rev VL - 50 UR - https://doi.org/10.1016/j.ctrv.2016.08.005 DO - 10.1016/j.ctrv.2016.08.005 ID - Bari2016 ER - TY - JOUR AU - Demanes, D. J. AU - Martinez, A. A. AU - Ghilezan, M. PY - 2011 DA - 2011// TI - High-dose-rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancer JO - Int J Radiat Oncol Biol Phys VL - 81 UR - https://doi.org/10.1016/j.ijrobp.2010.10.015 DO - 10.1016/j.ijrobp.2010.10.015 ID - Demanes2011 ER - TY - JOUR AU - Ghadjar, P. AU - Keller, T. AU - Rentsch, C. A. PY - 2009 DA - 2009// TI - Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy JO - Brachytherapy VL - 8 UR - https://doi.org/10.1016/j.brachy.2008.09.004 DO - 10.1016/j.brachy.2008.09.004 ID - Ghadjar2009 ER - TY - JOUR AU - Corner, C. AU - Rojas, A. M. AU - Bryant, L. PY - 2008 DA - 2008// TI - A phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer JO - Int J Radiat Oncol Biol Phys VL - 72 UR - https://doi.org/10.1016/j.ijrobp.2007.12.026 DO - 10.1016/j.ijrobp.2007.12.026 ID - Corner2008 ER - TY - JOUR AU - Martin, J. M. AU - Frantzis, J. AU - Eade, T. PY - 2010 DA - 2010// TI - Clinician's guide to prostate IMRT plan assessment and optimisation JO - J Med Imaging Radiat Oncol VL - 54 UR - https://doi.org/10.1111/j.1754-9485.2010.02217.x DO - 10.1111/j.1754-9485.2010.02217.x ID - Martin2010 ER - TY - JOUR AU - Fiorino, C. AU - Fellin, G. AU - Rancati, T. PY - 2008 DA - 2008// TI - Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study JO - Int J Radiat Oncol Biol Phys VL - 70 UR - https://doi.org/10.1016/j.ijrobp.2007.07.2354 DO - 10.1016/j.ijrobp.2007.07.2354 ID - Fiorino2008 ER - TY - JOUR AU - Cox, J. D. AU - Stetz, J. AU - Pajak, T. F. PY - 1995 DA - 1995// TI - Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) JO - Int J Radiat Oncol Biol Phys VL - 31 UR - https://doi.org/10.1016/0360-3016(95)00060-C DO - 10.1016/0360-3016(95)00060-C ID - Cox1995 ER - TY - JOUR AU - Kakehi, Y. AU - Takegami, M. AU - Suzukamo, Y. PY - 2007 DA - 2007// TI - Health related quality of life in Japanese men with localized prostate cancer treated with current multiple modalities assessed by a newly developed Japanese version of the expanded prostate Cancer index composite JO - J Urol VL - 177 UR - https://doi.org/10.1016/j.juro.2007.01.066 DO - 10.1016/j.juro.2007.01.066 ID - Kakehi2007 ER - TY - JOUR AU - Morgan, S. C. AU - Hoffman, K. AU - Loblaw, D. A. PY - 2019 DA - 2019// TI - Hypofractionated radiation therapy for localized prostate Cancer: executive summary of an ASTRO, ASCO and AUA evidence-based guideline JO - J Urol VL - 201 UR - https://doi.org/10.1097/JU.0000000000000071 DO - 10.1097/JU.0000000000000071 ID - Morgan2019 ER - TY - JOUR AU - Widmark, A. AU - Gunnlaugsson, A. AU - Beckman, L. PY - 2019 DA - 2019// TI - Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial JO - Lancet VL - 394 UR - https://doi.org/10.1016/S0140-6736(19)31131-6 DO - 10.1016/S0140-6736(19)31131-6 ID - Widmark2019 ER - TY - JOUR AU - Zelefsky, M. J. AU - Kollmeier, M. AU - McBride, S. PY - 2019 DA - 2019// TI - 5-year outcomes of a phase I dose escalation study using stereotactic body radiosurgery for patients with low and intermediate risk prostate Cancer JO - Int J Radiat Oncol Biol Phys VL - 104 UR - https://doi.org/10.1016/j.ijrobp.2018.12.045 DO - 10.1016/j.ijrobp.2018.12.045 ID - Zelefsky2019 ER - TY - JOUR AU - Hannan, R. AU - Tumati, V. AU - Xie, X. J. PY - 2016 DA - 2016// TI - Stereotactic body radiation therapy for low and intermediate risk prostate cancer-results from a multi-institutional clinical trial JO - Eur J Cancer VL - 59 UR - https://doi.org/10.1016/j.ejca.2016.02.014 DO - 10.1016/j.ejca.2016.02.014 ID - Hannan2016 ER - TY - JOUR AU - McBride, S. e. a. n. M. AU - Wong, D. o. u. g. l. a. s. S. AU - Dombrowski, J. o. h. n. J. AU - Harkins, B. o. n. n. i. e. AU - Tapella, P. a. t. r. i. c. i. a. AU - Hanscom, H. e. a. t. h. e. r. N. AU - Collins, S. e. a. n. P. AU - Kaplan, I. r. v. i. n. g. D. PY - 2011 DA - 2011// TI - Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma JO - Cancer VL - 118 UR - https://doi.org/10.1002/cncr.26699 DO - 10.1002/cncr.26699 ID - McBride2011 ER - TY - JOUR AU - Brenner, D. a. v. i. d. J. PY - 2004 DA - 2004// TI - Fractionation and late rectal toxicity JO - International Journal of Radiation Oncology*Biology*Physics VL - 60 UR - https://doi.org/10.1016/j.ijrobp.2004.04.014 DO - 10.1016/j.ijrobp.2004.04.014 ID - Brenner2004 ER - TY - JOUR AU - Brenner, D. J. AU - Hall, E. J. PY - 1999 DA - 1999// TI - Fractionation and protraction for radiotherapy of prostate carcinoma JO - Int J Radiat Oncol Biol Phys VL - 43 UR - https://doi.org/10.1016/S0360-3016(98)00438-6 DO - 10.1016/S0360-3016(98)00438-6 ID - Brenner1999 ER - TY - JOUR AU - King, C. R. AU - Brooks, J. D. AU - Gill, H. PY - 2012 DA - 2012// TI - Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer JO - Int J Radiat Oncol Biol Phys VL - 82 UR - https://doi.org/10.1016/j.ijrobp.2010.11.054 DO - 10.1016/j.ijrobp.2010.11.054 ID - King2012 ER -